]> 2026-10-07T13:00:44+02:00 Document:GBR MHRA GCP Inspection Dossier template V7.0 3000 en GCP Inspection Dossier template The following information is requested specifically in relation to clinical trials undertaken (for Investigational Medicinal Products) within the UK and should be provided within 30 days of the advance notice email date. Note: the scope of the dossier request will be determined in the notification email you have received. If your organisation has been selected for a systems inspection, this dossier should be completed with all trial activities in scope. If you have been informed of our intention to conduct a trial specific inspection the dossier (and associated attachments) should be related to the selected trial(s) only. EN MHRA GCP Inspection Dossier template GBR MHRA GCP Inspection Dossier template V7.0 No G Current Florian Adragna Information from official body GBR V7.0 2026-07-16T12:15:32Z 2461238.010787 GBR MHRA GCP Inspection Dossier template V7.0 3000 1 table 3 [[Reference:+]] [[HasDocument::Document:GBR MHRA GCP Inspection Dossier template V7.0]] GBR MHRA GCP Inspection Dossier template V7.0# QUERY465634e30737ba78b3bb66a44e98a1be Reference:GBR MHRA GCP Inspection Dossier template V7.0 - 3002 en GBR MHRA GCP Inspection Dossier template V7.0 - HasDocument 102 en HasDocument